Arecor Therapeutics plc (AREC) ORD GBP0.01
- Add to watchlist
- Create an alert
- This stock can be held in a
54.50p
n/a
170.00p
£20.58 million
54.50p
n/a
54.50p
n/a
2.00p (3.54%) Previous:
2.00p
n/a
n/a
1,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue (£m) | 4.57 | 2.40 |
Profit before tax (£m) | (8.90) | (10.54) |
Adjusted EPS (p): | (28.00) | (32.00) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Revenue higher, cash reserves fall at Arecor
3 February 2025 14:40
-
Arecor to wind up operations at Tetris Pharma subsidiary
10 January 2025 14:59
-
Arecor upbeat on signing of exclusive licensing deal
30 December 2024 10:05
-
Arecor Full Year 2024 Trading Update
3 February 2025 07:00
-
Orderly Cessation of Tetris Pharma Operations
10 January 2025 07:45
-
Change of Nominated Advisor and Joint Broker
9 January 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.